ADAM22, full name a disintegrin and metalloproteinase 22. It is a transmembrane protein expressed in the nervous system, regulating neural cell adhesion, synapse formation and neural development. ADAM22 dysfunction causes epilepsy, intellectual disability and neurodegeneration, and correlates with brain tumors. ADAM22 modulators are under preclinical research for neurological disorders.
Validated Data
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
The following ADAM22 reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
ADAM22 Proteins for Homo sapiens (Human)
| Code | Product Name | Source |
|---|---|---|
| CSB-YP865198HU CSB-BP865198HU CSB-MP865198HU CSB-EP865198HU-B |
Recombinant Human Disintegrin and metalloproteinase domain-containing protein 22 (ADAM22), partial | Yeast Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
| CSB-EP865198HU | Recombinant Human Disintegrin and metalloproteinase domain-containing protein 22 (ADAM22), partial | E.coli |